Morita, R., Yamamoto, S., Imazeki, H., Takahashi, H., Honma, Y., Kurita, D., Ishiyama, K., Kashihara, T., Daiko, H., Seto, Y., Kato, K. (2026). Induction DCF plus nivolumab versus induction DCF for unresectable locally advanced esophageal squamous cell carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.316